GeneDx Holdings Corp. (WGS)

NMS – Цена в реальном времени. Валюта: USD

82.08

+0.34 (0.42%)

Рынок открыт: Aug 12, 2026, 12:49 PM EDT

80.11

-1.63 (-1.99%)

Предыдущая сессия: Aug 11, 2026, 7:58 PM EDT

Обзор
Новости
График
Финансы
Дивиденды
Прогноз
Владельцы
Профиль

GeneDx Holdings Corp. (WGS)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

GeneDx Holdings Corp. (WGS)

GeneDx Launches New Online Offering for Families to Improve Accessibility of Exome Testing for Children with Global Developmental Delay, Intellectual Disability and Epilepsy

GeneDx to Participate in Upcoming Investor Conferences

Alger Small Cap Focus Fund Q2 2026 Portfolio Review

GeneDx Holdings Corp. (WGS) Q2 2026 Earnings Call Transcript

GeneDx Q2 Earnings Call Highlights

GeneDx Holdings Corp. (WGS) Q2 Earnings and Revenues Surpass Estimates

GeneDx Reports Second Quarter 2026 Financial Results

Видео

No Data

Пресс-релизы

GeneDx Launches New Online Offering for Families to Improve Accessibility of Exome Testing for Children with Global Developmental Delay, Intellectual Disability and Epilepsy

GeneDx Reports Second Quarter 2026 Financial Results

Bronstein, Gewirtz & Grossman LLC Urges GeneDx Holdings Corp. Investors to Act: Class Action Filed Alleging Investor Harm

CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026

Search stocks

GeneDx Holdings Corp. (WGS)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

GeneDx Holdings Corp. (WGS)

GeneDx Launches New Online Offering for Families to Improve Accessibility of Exome Testing for Children with Global Developmental Delay, Intellectual Disability and Epilepsy

GeneDx to Participate in Upcoming Investor Conferences

Alger Small Cap Focus Fund Q2 2026 Portfolio Review

GeneDx Holdings Corp. (WGS) Q2 2026 Earnings Call Transcript

GeneDx Q2 Earnings Call Highlights

GeneDx Holdings Corp. (WGS) Q2 Earnings and Revenues Surpass Estimates

GeneDx Reports Second Quarter 2026 Financial Results

Видео

No Data

Пресс-релизы

GeneDx Launches New Online Offering for Families to Improve Accessibility of Exome Testing for Children with Global Developmental Delay, Intellectual Disability and Epilepsy

GeneDx Reports Second Quarter 2026 Financial Results

Bronstein, Gewirtz & Grossman LLC Urges GeneDx Holdings Corp. Investors to Act: Class Action Filed Alleging Investor Harm

CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026